Connect with us

Health

Pancreatic cancer clinical trial program to target genome and scar tissue – UNSW Newsroom

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.

Published

on

Article feature image

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoSTP), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending